ATE228849T1 - Behandlung des typ ii-deabetes mellitus mit amylinagonisten - Google Patents
Behandlung des typ ii-deabetes mellitus mit amylinagonistenInfo
- Publication number
- ATE228849T1 ATE228849T1 AT96921467T AT96921467T ATE228849T1 AT E228849 T1 ATE228849 T1 AT E228849T1 AT 96921467 T AT96921467 T AT 96921467T AT 96921467 T AT96921467 T AT 96921467T AT E228849 T1 ATE228849 T1 AT E228849T1
- Authority
- AT
- Austria
- Prior art keywords
- mellitus
- type
- deabetes
- treatment
- amylin agonists
- Prior art date
Links
- 229940127438 Amylin Agonists Drugs 0.000 title 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 abstract 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/483,188 US6143718A (en) | 1995-06-07 | 1995-06-07 | Treatment of Type II diabetes mellutis with amylin agonists |
| PCT/US1996/009875 WO1996040220A1 (en) | 1995-06-07 | 1996-06-07 | Treatment of type ii diabetes mellitus with amylin agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE228849T1 true ATE228849T1 (de) | 2002-12-15 |
Family
ID=23919034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96921467T ATE228849T1 (de) | 1995-06-07 | 1996-06-07 | Behandlung des typ ii-deabetes mellitus mit amylinagonisten |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6143718A (enEXAMPLES) |
| EP (1) | EP0772451B1 (enEXAMPLES) |
| JP (1) | JP4009319B2 (enEXAMPLES) |
| AT (1) | ATE228849T1 (enEXAMPLES) |
| AU (1) | AU721489B2 (enEXAMPLES) |
| BG (1) | BG101230A (enEXAMPLES) |
| CA (1) | CA2196999C (enEXAMPLES) |
| CZ (1) | CZ289043B6 (enEXAMPLES) |
| DE (1) | DE69625157T2 (enEXAMPLES) |
| DK (1) | DK0772451T3 (enEXAMPLES) |
| ES (1) | ES2187659T3 (enEXAMPLES) |
| HU (1) | HUP9700368A3 (enEXAMPLES) |
| IN (1) | IN181672B (enEXAMPLES) |
| NO (1) | NO970519L (enEXAMPLES) |
| PT (1) | PT772451E (enEXAMPLES) |
| RU (1) | RU2166958C2 (enEXAMPLES) |
| SK (1) | SK18697A3 (enEXAMPLES) |
| WO (1) | WO1996040220A1 (enEXAMPLES) |
| ZA (1) | ZA964838B (enEXAMPLES) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| BR9407424A (pt) * | 1993-09-07 | 1996-04-09 | Amylin Pharmaceuticals Inc | Métodos para regular motilidade gastrointestinal |
| US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
| US7312196B2 (en) | 1997-01-08 | 2007-12-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
| US6410511B2 (en) | 1997-01-08 | 2002-06-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
| US7101853B2 (en) * | 1997-05-06 | 2006-09-05 | Amylin Pharmaceuticals, Inc. | Method for treating or preventing gastritis using amylin or amylin agonists |
| US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
| AU760609B2 (en) * | 1998-01-09 | 2003-05-15 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
| US6087334A (en) * | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
| EP1474164B1 (en) * | 2002-01-08 | 2008-10-29 | Amylin Pharmaceuticals, Inc. | Use of amylin, amylin analogs and amylin derivatives to treat dyslipidemia and triglyceridemia |
| EP1656368A4 (en) * | 2002-07-09 | 2009-08-26 | Bristol Myers Squibb Co | SUBSTITUTED HETEROCYCLIC DERIVATIVES USEFUL AS ANTIDIABETIC AGENTS AND ANTIABESITY AND THEIR MANUFACTURING PROCESS |
| MXPA05012278A (es) * | 2003-05-14 | 2006-02-10 | Emisphere Tech Inc | Composiciones para suministrar peptido yy y combatientes pyy. |
| US8501473B2 (en) * | 2003-07-16 | 2013-08-06 | Evotec International Gmbh | Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| NZ549332A (en) * | 2004-02-11 | 2008-11-28 | Amylin Pharmaceuticals Inc | Amylin family peptides and methods for making and using them |
| BRPI0506793A (pt) * | 2004-02-20 | 2007-05-22 | Rinat Neuroscience Corp | métodos de tratamento de obesidade ou diabetes com o uso de nt-4/5 |
| US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
| NZ561400A (en) * | 2005-03-11 | 2010-02-26 | Endo Pharmaceuticals Solutions | Controlled release formulations of octreotide |
| US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
| DOP2007000021A (es) * | 2006-02-02 | 2007-08-31 | Rinat Neuroscience Corp | Procedimientos para tratar pérdida de peso no deseada o trastornos alimentarios administrando un agonista de trkb |
| WO2007088479A1 (en) * | 2006-02-02 | 2007-08-09 | Rinat Neuroscience Corp. | Methods for treating obesity by administering a trkb antagonist |
| CA2672750A1 (en) * | 2006-12-20 | 2008-07-03 | Rinat Neuroscience Corporation | Trkb agonists for treating autoimmune disorders |
| CA2705708A1 (en) * | 2007-11-14 | 2009-05-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity and obesity related diseases and disorders |
| KR20110025974A (ko) * | 2008-06-25 | 2011-03-14 | 엔도 파마슈티컬즈, 솔루션스 아이엔씨. | 이형제를 함유하는 옥트레오티드 이식물 |
| US8071537B2 (en) | 2008-06-25 | 2011-12-06 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the sustained release of a polypeptide |
| CR20170369A (es) | 2008-10-17 | 2017-11-01 | Sanofi Aventis Deutschland | COMBINACIÓN DE UNA INSULINA Y UN AGONISTA DE GLP-1 (Divisional 2011-0188) |
| JP2009149684A (ja) * | 2009-03-11 | 2009-07-09 | Amylin Pharmaceut Inc | アミリン作動薬ペプチド用製剤 |
| EP2762150A1 (en) * | 2009-03-12 | 2014-08-06 | Nordic Bioscience A/S | Treatment of Diabetes and Metabolic Syndrome |
| US20110118180A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
| PL2498802T3 (pl) | 2009-11-13 | 2015-06-30 | Sanofi Aventis Deutschland | Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę |
| US20110118178A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin |
| WO2011058082A1 (de) | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin |
| SG187904A1 (en) | 2010-08-30 | 2013-04-30 | Sanofi Aventis Deutschland | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| EP2750699B1 (en) | 2011-08-29 | 2015-07-22 | Sanofi-Aventis Deutschland GmbH | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| BR102013017626A2 (pt) * | 2013-06-14 | 2015-02-10 | Univ Rio De Janeiro | Bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, uso de bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, composições farmacêuticas de baixa toxicidade, adjuvante para a prevenção ou tratamento das doenças, medicamento, método de tratamento ou prevenção de doenças. |
| AR101742A1 (es) * | 2014-09-04 | 2017-01-11 | Novo Nordisk As | Agonista del receptor de calcitonina y amilina |
| EP3229828B1 (en) | 2014-12-12 | 2023-04-05 | Sanofi-Aventis Deutschland GmbH | Insulin glargine/lixisenatide fixed ratio formulation |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
| US5367052A (en) * | 1987-04-27 | 1994-11-22 | Amylin Pharmaceuticals, Inc. | Amylin peptides |
| US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
| US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
| US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
| US5321008A (en) * | 1991-01-10 | 1994-06-14 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| US5264372A (en) * | 1991-03-15 | 1993-11-23 | Amylin Pharmaceuticals, Inc. | Receptor-based screening methods for amylin agonists and antagonists |
| HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| CA2100745C (en) * | 1991-11-19 | 2007-07-31 | Laura S. L. Gaeta | Amylin agonist peptides and uses therefor |
| US5376638A (en) * | 1992-09-01 | 1994-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating renin-related disorders with amylin antagonists |
| BR9407424A (pt) * | 1993-09-07 | 1996-04-09 | Amylin Pharmaceuticals Inc | Métodos para regular motilidade gastrointestinal |
| US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
| US6087334A (en) | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
-
1995
- 1995-06-07 US US08/483,188 patent/US6143718A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 ZA ZA9604838A patent/ZA964838B/xx unknown
- 1996-06-07 WO PCT/US1996/009875 patent/WO1996040220A1/en not_active Application Discontinuation
- 1996-06-07 EP EP96921467A patent/EP0772451B1/en not_active Expired - Lifetime
- 1996-06-07 CZ CZ1997337A patent/CZ289043B6/cs not_active IP Right Cessation
- 1996-06-07 RU RU97104029/14A patent/RU2166958C2/ru not_active IP Right Cessation
- 1996-06-07 AU AU62685/96A patent/AU721489B2/en not_active Ceased
- 1996-06-07 AT AT96921467T patent/ATE228849T1/de active
- 1996-06-07 ES ES96921467T patent/ES2187659T3/es not_active Expired - Lifetime
- 1996-06-07 SK SK186-97A patent/SK18697A3/sk unknown
- 1996-06-07 JP JP50206197A patent/JP4009319B2/ja not_active Expired - Fee Related
- 1996-06-07 PT PT96921467T patent/PT772451E/pt unknown
- 1996-06-07 HU HU9700368A patent/HUP9700368A3/hu unknown
- 1996-06-07 CA CA2196999A patent/CA2196999C/en not_active Expired - Fee Related
- 1996-06-07 IN IN1053CA1996 patent/IN181672B/en unknown
- 1996-06-07 DE DE69625157T patent/DE69625157T2/de not_active Expired - Lifetime
- 1996-06-07 DK DK96921467T patent/DK0772451T3/da active
-
1997
- 1997-02-05 NO NO970519A patent/NO970519L/no unknown
- 1997-02-13 BG BG101230A patent/BG101230A/xx unknown
-
2000
- 2000-11-06 US US09/707,370 patent/US6417164B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| RU2166958C2 (ru) | 2001-05-20 |
| US6143718A (en) | 2000-11-07 |
| AU721489B2 (en) | 2000-07-06 |
| HU9700368D0 (en) | 1997-04-28 |
| BG101230A (en) | 1997-10-31 |
| DE69625157T2 (de) | 2003-04-17 |
| EP0772451A1 (en) | 1997-05-14 |
| WO1996040220A1 (en) | 1996-12-19 |
| AU6268596A (en) | 1996-12-30 |
| CZ289043B6 (cs) | 2001-10-17 |
| DK0772451T3 (da) | 2003-01-06 |
| NO970519D0 (no) | 1997-02-05 |
| CA2196999C (en) | 2012-09-04 |
| SK18697A3 (en) | 1998-02-04 |
| HUP9700368A2 (hu) | 1998-06-29 |
| NO970519L (no) | 1997-04-07 |
| DE69625157D1 (de) | 2003-01-16 |
| PT772451E (pt) | 2003-04-30 |
| JP4009319B2 (ja) | 2007-11-14 |
| CZ33797A3 (en) | 1997-07-16 |
| US6417164B1 (en) | 2002-07-09 |
| IN181672B (enEXAMPLES) | 1998-08-29 |
| JPH10503785A (ja) | 1998-04-07 |
| ZA964838B (en) | 1997-02-24 |
| EP0772451A4 (en) | 1998-09-30 |
| CA2196999A1 (en) | 1996-12-19 |
| ES2187659T3 (es) | 2003-06-16 |
| EP0772451B1 (en) | 2002-12-04 |
| HUP9700368A3 (en) | 2001-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE228849T1 (de) | Behandlung des typ ii-deabetes mellitus mit amylinagonisten | |
| EA199800316A1 (ru) | СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ | |
| DK0867178T3 (da) | Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser | |
| EE03202B1 (et) | Intravaginaalne manustussüsteem ja selle valmistamismeetod | |
| EA199800626A1 (ru) | Применение агониста ppar-гамма для лечения синдрома х | |
| DK0514452T4 (da) | Anvendelse af insulin-sensibiliserende midler til behandling af hypertension | |
| EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
| EA200101089A1 (ru) | Новый способ лечения | |
| NO883306D0 (no) | Farmasoeytisk aktive konjugater med forbedret bindingsspesifisitet for kroppsvev. | |
| DK0863760T3 (da) | Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning | |
| CY1105254T1 (el) | Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο | |
| EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
| EA199800317A1 (ru) | СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ | |
| BR9810444A (pt) | Tratamento de diabete com rosiglitazona e insulina | |
| EA200100133A1 (ru) | Оксазолидиноны для лечения инфекционных болезней глаз | |
| EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
| EA200000039A1 (ru) | Лечение диабета тиазолидиндионом и сульфонилмочевиной | |
| BR9810186A (pt) | Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade | |
| RU94042315A (ru) | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки | |
| NO993069L (no) | Ny anvendelse av dipeptider | |
| EA199800822A1 (ru) | Способ лечения избыточной агрессии | |
| TR200000957T2 (tr) | Hiperglisemi tedavisinde tiazolidinedion kullanımı | |
| EA199800820A1 (ru) | Способ лечения злоупотребления лекарственными средствами | |
| NO974941L (no) | Ny anvendelse av (S)-adenosyl-L-metionin(SAMe) | |
| UA43389C2 (uk) | Спосіб зниження рівнів кальцію у сироватці |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0772451 Country of ref document: EP |